Loading...
XSHE
300030
Market cap344mUSD
Dec 05, Last price  
7.87CNY
1D
0.51%
1Q
-2.24%
Jan 2017
-42.38%
IPO
112.20%
Name

GZ IMPROVE MEDICAL INSTRUMENTS CO.

Chart & Performance

D1W1MN
XSHE:300030 chart
P/E
—
P/S
4.19
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.10%
Rev. gr., 5y
0.22%
Revenues
581m
-9.82%
44,121,17672,321,065103,447,988140,793,354165,866,083249,639,335304,084,984396,737,493461,792,180545,348,932517,103,043549,652,842549,963,261575,061,342919,225,503799,833,986710,768,471644,621,152581,328,009
Net income
-118m
L+86.55%
8,344,55213,190,02320,462,03626,905,04029,020,72135,674,85537,472,26046,119,86353,057,20839,835,20930,477,44011,158,462026,024,206162,515,16318,568,5290-63,203,837-117,903,784
CFO
82m
+2.42%
6,570,9942,651,19824,764,33333,034,20928,855,39838,862,92036,062,20444,381,2530023,185,032142,192,98056,036,17749,162,409141,274,052171,738,97242,478,05879,904,93281,835,065
Dividend
Jul 06, 20220.04 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Improve Medical Instruments Co., Ltd. provides technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. Its principal products include IMPROVACUTER evacuated blood collection systems, IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transportation systems, IMPRONURSE infusion pumps and syringe pumps, LONGX urine analysis systems, in-vitro diagnostic reagents, etc. The company also provides blood collection needles, pulsewave blood pressure monitors, thrombosis viscoelastic analysis systems, feces analysis systems, blood collection tube preparation systems, graphic user interface devices, intelligent sorters, multi-function blood collection tables, intelligent queue systems, urine collection tube preparation systems, automatic tube packer systems, and consumable labels. The company was formerly known as Guangzhou Improve Medical Instruments Co., Ltd. Improve Medical Instruments Co., Ltd. was founded in 1996 and is headquartered in Guangzhou, China.
URL
https://www.improve-medical.com/
IPO date
Dec 25, 2009
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT